Instructions for Noocil (Citicoline) 19 vials 100 mg
English product name
Noocil
Release form
p-r d/ingestion 100 mg/ml: fl 10 ml 3 or 10 pcs
Description:
The solution is transparent, colorless or slightly yellowish, with a characteristic smell.
1 ml
sodium cyticoline 104.5 mg,
which corresponds to the content of cyticoline 100 mg
Auxiliary substances: methylparahydroxybenzoate - 1.45 mg, propyl parahydroxybenzoate - 0.25 mg, potassium sorbat - 3 mg, sodium saccharinate - 0.2 mg, sorbitol - 200 mg, glycerol - 50 mg, sodium citrate - 6 mg, strawberry flavoring - 0.41 mg, citric acid - 1 mg, water purified - up to 1 ml.
ATC codes
N06BX06 Citicoline
Active substance
tsitikolin
Pharmacotherapy group Noocil
Nootropic agent
Storage Conditions
The drug Noocil should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is three years. Do not apply after expiry date.
Testimony Citicoline:
- acute period of ischemic stroke (cerebral infarction) (as part of complex therapy);
- Recovery period of ischemic and haemorrhagic stroke;
- Brain injury (BMI): acute (as part of complex therapy) and recovery period;
- Cognitive and behavioural disorders in degenerative and vascular brain diseases.
Method of use, course and dosage Citicoline:
The drug is taken inside, during meals or between meals. Before use, the solution can be diluted in a small amount of water (one hundred and twenty ml or 1/2 cup).
Acute period of ischemic stroke and brain injury (OCD): 1000 mg (ten ml) every twelve hours. Treatment duration of at least six weeks.
The recovery period of ischemic and hemorrhagic strokes, the recovery period of BMI, cognitive and behavioral disorders in degenerative and vascular diseases of the brain: 500-2000 mg/day (five - ten ml once - twice a day). The dose and duration of treatment depends on the severity of the symptoms.
No dose correction is required for elderly patients.
Application in elderly patients
No dose correction is required for elderly patients.
Use in children Noocil
The use of the preparation in patients aged up to 18 years is contraindicated.
- Nosology Citicoline (ICD codes)
- F07
- Personality and behavioural disorders caused by disease, damage or brain dysfunction
- I63
- Brain infarction
- I69
- Effects of cerebrovascular disease
- S06
- Intracranial injury
- T90
- Effects of head injuries
Pharmacological effect Noocil:
Being a precursor of the key ultrastostructural components of the cell membrane (mainly phospholipids), cyticoline has a broad spectrum of action - it promotes the repair of damaged cell membranes, inhibits the action of phospholipases, inhibits the excessive formation of free radicals, and prevents cell death by acting on the mechanisms of apoptosis. In the acute stroke period, Citicoline reduces the amount of damage to brain matter and improves cholinergic transmission. In traumatic brain injury, reduces the duration of the post-traumatic coma and the expression of neurological symptoms, in addition, contributes to a reduction in the length of the recovery period.
